EmGenisys

Improving breeding success with real-time embryo health evaluation

EmGenisys is enabling genetic progress in animal production by maximizing the efficiency of in vitro fertilization (IVF) and embryo transfer (ET). Using computer vision to train machine learning models to analyze embryo cell changes, EmGenisys developed a noninvasive, onsite software test to evaluate embryo health in real-time. The result is a comprehensive embryo health evaluation which delivers standardized and consistent results, empowering ET practitioners to manage their embryo programs with objective data and improve pregnancy outcomes of IVF/ET up to 20%.

EmGenisys logo

WEBSITE
emgenisys.co

CEO
Cara Wells, PhD

FROM
Houston, TX

SOCIAL

WATCH THE OVERVIEW